Aristo Bio-Tech and Lifescience (ARISTO) Stock Overview
Engages in the manufacturing, formulation, supply, packaging, and job work services for various pesticides in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
ARISTO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Aristo Bio-Tech and Lifescience Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹132.00 |
| 52 Week High | ₹164.00 |
| 52 Week Low | ₹84.55 |
| Beta | -0.68 |
| 1 Month Change | -0.53% |
| 3 Month Change | 7.93% |
| 1 Year Change | -8.14% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 57.14% |
Recent News & Updates
Recent updates
Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Soars 26% But It's A Story Of Risk Vs Reward
Sep 18
Take Care Before Diving Into The Deep End On Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
Jul 03Estimating The Intrinsic Value Of Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
May 31Do Aristo Bio-Tech and Lifescience's (NSE:ARISTO) Earnings Warrant Your Attention?
Mar 27Is Aristo Bio-Tech and Lifescience (NSE:ARISTO) A Risky Investment?
Feb 12Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Doing What It Can To Lift Shares
Oct 30Is Aristo Bio-Tech and Lifescience (NSE:ARISTO) Using Too Much Debt?
Aug 22Potential Upside For Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO) Not Without Risk
Jun 29If EPS Growth Is Important To You, Aristo Bio-Tech and Lifescience (NSE:ARISTO) Presents An Opportunity
Mar 22Shareholder Returns
| ARISTO | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 1.5% | -0.7% | 0.3% |
| 1Y | -8.1% | -6.0% | 0.7% |
Return vs Industry: ARISTO underperformed the Indian Chemicals industry which returned -4.7% over the past year.
Return vs Market: ARISTO underperformed the Indian Market which returned 1.9% over the past year.
Price Volatility
| ARISTO volatility | |
|---|---|
| ARISTO Average Weekly Movement | 8.4% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in IN Market | 8.4% |
| 10% least volatile stocks in IN Market | 3.2% |
Stable Share Price: ARISTO's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: ARISTO's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 66 | Narendra Barhat | www.aristobiotech.com |
Aristo Bio-Tech and Lifescience Limited engages in the manufacturing, formulation, supply, packaging, and job work services for various pesticides in India and internationally. The company offers insecticides, herbicides, weedicides, fungicides, plant growth regulators, fertilizers, and other agrochemicals. It offers its products under the Machete, Lasso, Fastmix, Roundup Speed, Seamer, and Vam C (Ramban) brand names.
Aristo Bio-Tech and Lifescience Limited Fundamentals Summary
| ARISTO fundamental statistics | |
|---|---|
| Market cap | ₹898.63m |
| Earnings (TTM) | ₹40.63m |
| Revenue (TTM) | ₹3.18b |
Is ARISTO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARISTO income statement (TTM) | |
|---|---|
| Revenue | ₹3.18b |
| Cost of Revenue | ₹2.96b |
| Gross Profit | ₹222.43m |
| Other Expenses | ₹181.80m |
| Earnings | ₹40.63m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.97 |
| Gross Margin | 6.99% |
| Net Profit Margin | 1.28% |
| Debt/Equity Ratio | 58.5% |
How did ARISTO perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/31 09:01 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aristo Bio-Tech and Lifescience Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.